Genomic characterization in triple-negative primary myelofibrosis and other myeloid neoplasms with bone marrow fibrosis-Reference-Cited by-同舟云学术

Genomic characterization in triple-negative primary myelofibrosis and other myeloid neoplasms with bone marrow fibrosis

Published:2019-08-08 Issue:10 Volume:98 Page:2319-2328
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Alvarez-Larrán Alberto^ORCID,López-Guerra Mónica,Rozman María,Correa Juan-Gonzalo,Hernández-Boluda Juan Carlos,Tormo Mar,Martínez Daniel,Martín Iván,Colomer Dolors,Esteve Jordi,Cervantes Francisco

Funder

Instituto Salud Carlos III

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-019-03766-z.pdf

Reference24 articles.

1. Arber D, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391–2405

2. Tefferi A, Guglielmelli P, Larson DR, Finke C, Wassie EA, Pieri L, Gangat N, Fjerza R, Belachew AA, Lasho TL, Ketterling RP, Hanson CA, Rambaldi A, Finazzi G, Thiele J, Barbui T, Pardanani A, Vannucchi AM (2014) Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood 124:2507–2513

3. Tefferi A, Lasho TL, Finke CM, Knudson RA, Ketterling R, Hanson CH, Maffioli M, Caramazza D, Passamonti F, Pardanani A (2014) CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons. Leukemia 28:1472–1477

4. Tefferi A, Nicolosi M, Mudireddy M, Szuber N, Finke CM, Lasho TL, Hanson CA, Ketterling RP, Pardanani A, Gangat N, Mannarelli C, Fanelli T, Guglielmelli P, Vannucchi AM (2018) Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients. Am J Hematol 93:348–355

5. Maschek H, Georgii A, Kaloutsi V, Werner M, Bandecar K, Kressel MG, Choritz H, Freund M, Hufnagl D (1992) Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients. Eur J Haematol 48:208–214

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes;Clinical Lymphoma Myeloma and Leukemia;2024-07

2. Sequential gene expression analysis of myelodysplastic syndrome transformation identifies HOXB3 and HOXB7 as the novel targets for mesenchymal cells in disease;BMC Cancer;2024-01-22

3. Idiopathic erythrocytosis: a germline disease?;Clinical and Experimental Medicine;2024-01-20

4. Molecular testing in myeloproliferative neoplasms;Diagnostic Molecular Pathology;2024

5. Understanding triple negative myeloproliferative neoplasms: pathogenesis, clinical features, and management;Leukemia & Lymphoma;2023-11-30